ABI Live Webinars, 2023

Sponsored by Epiq Bankruptcy
Year-over-year bankruptcy filings are poised to show solid increases across most chapters in 1Q 2023. What categories of consumer and business filings are showing the largest growth? How do filings compare among different stakeholders and regions of the U.S., and will the trends continue in the year ahead? Join ABI and statistical partner Epiq Bankruptcy Analytics for a special abiLIVE webinar during which experts will discuss first-quarter filings, and what trends might lie ahead.

Many bankrupt businesses need financial assistance to pay their administrative expenses and creditors and to help them survive bankruptcy. The employee retention credit (ERC) is one way to solve this problem. This session will cover the basics of the ERC program, how your clients can qualify for and benefit from the ERC, and some common ERC pitfalls to avoid. The presentation will include a Q&A period.

Hosted by the Consumer Bankruptcy Committee

Join our panelists as they discuss the DOJ’s new student loan guidelines and provide context on how the guidelines will impact debtor attorneys, trustees and other entities in the bankruptcy process.

The first half of 2022 set a First Day record for fewest chapter 11 filings over any calendar six-month period, but chapter 11s picked up in the second half of the year, with Q4 concluding as the year’s busiest quarter and December closing out as the year's busiest month. Ignoring real estate cases, which peaked in 2021, the frequency of chapter 11 cases fell by only 1% in 2022. Despite the waning of COVID-19, companies continue to cite the pandemic as at least part of the reason for their bankruptcy filings.

On direct appeal, the Third Circuit on Jan. 30 reversed the bankruptcy court and directed the dismissal of the petition that had been filed by LTL Management LLC, the subsidiary of Johnson & Johnson created to file in chapter 11 to deal with talc and asbestos claims arising from the sale of Johnson’s Baby Powder. Although Circuit Judge Thomas Ambro pointedly declined to rule on whether LTL improperly used chapter 11 as a “litigation tactic,” what are the legal steps J&J can take to settle roughly 40,000 cancer lawsuits concerning its talc-based products?